No photo of Christine Chen

Christine Chen

Adj ClinAssProf

20142016
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2014 2016

7 Citations (Scopus)

What are the similarities and differences in antimicrobial prescribing between Australian public and private hospitals?

Cotta, M. O., Chen, C., Tacey, M., James, R. S., Buising, K. L., Marshall, C. & Thursky, K. A., Oct 2016, In : Internal Medicine Journal. 46, 10, p. 1182-1188 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
24 Citations (Scopus)

Baseline predictors for good versus poor visual outcomes in the treatment of neovascular age-related macular degeneration with intravitreal anti-VEGF therapy

Chae, B., Jung, J. J., Mrejen, S., Gallego-Pinazo, R., Yannuzzi, N. A., Patel, S. N., Chen, C. Y., Marsiglia, M., Boddu, S. & Freund, K. B., 2015, In : Investigative Ophthalmology and Visual Science. 56, 9, p. 5040 - 5047 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
23 Citations (Scopus)

Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration

Marsiglia, M., Boddu, S., Chen, C. Y., Jung, J. J., Mrejen, S., Gallego-Pinazo, R. & Freund, K. B., 2015, In : Retina-The Journal of Retinal and Vitreous Diseases. 35, 5, p. 966 - 974 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Long-term visual outcomes for a treat and extend anti-vascular endothelial growth factor regimen in eyes with neovascular age-related macular degeneration

Mrejen, S., Jung, J. J., Chen, C. Y., Patel, S. N., Gallego-Pinazo, R., Yannuzzi, N. A., Xu, L., Marsiglia, M., Boddu, S. & Freund, K. B., 2015, In : Journal of Clinical Medicine. 4, 7, p. 1380 - 1402 23 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
20 Citations (Scopus)

A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia

Awan, F. T., Hillmen, P., Hellmann, A., Robak, T., Hughes, S. G., Trone, D., Shannon, M., Flinn, I. W., Byrd, J. C. & LUCID trial investigators, 1 Nov 2014, In : British Journal of Haematology. 167, 4, p. 466-477 12 p.

Research output: Contribution to journalArticleResearchpeer-review